Mammography radiomics features at diagnosis and progression-free survival among patients with breast cancer

被引：0
|
作者：
Chuanxu Luo
Shuang Zhao
Cheng Peng
Chengshi Wang
Kejia Hu
Xiaorong Zhong
Ting Luo
Juan Huang
Donghao Lu
机构：
[1] Sichuan University,Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, West China Hospital
[2] West China Hospital of Sichuan University,Department of Radiology
[3] Brigham and Women’s Hospital,Channing Division of Network Medicine
[4] University of Electronic Science and Technology of China,Department of breast surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine
[5] Institute of Environmental Medicine,Unit of Integrative Epidemiology
[6] Karolinska Institute,Department of Head, Neck and Mammary Gland Oncology
[7] Cancer Center,West China Biomedical Big Data Center
[8] West China Hospital,undefined
[9] Sichuan University,undefined
[10] West China Hospital,undefined
[11] Sichuan University,undefined
来源：
British Journal of Cancer | 2022年 / 127卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1886 / 1892
页数：6
相关论文
共 50 条
  • [21] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [22] A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer
    Wang, Z.
    Zhao, Z.
    Li, W.
    Bao, X.
    Liu, T.
    Yang, X.
    CLINICAL ONCOLOGY, 2023, 35 (09) : e516 - e527
  • [23] Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
    Goldvaser, Hadar
    Ribnikar, Domen
    Fazelzad, Rouhi
    Seruga, Bostjan
    Templeton, Arnoud J.
    Ocana, Alberto
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2017, 59 : 46 - 53
  • [24] Sorafenib Plus Chemotherapy Significantly Prolongs Progression-Free Survival in Advanced Breast Cancer Patients
    不详
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 931 - 931
  • [25] Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
    Goldvaser, Hadar
    Ribnikar, Domen
    Fazelzad, Rouhi
    Seruga, Bostjan
    Templeton, Arnoud J.
    Ocana, Alberto
    Amir, Eitan
    CANCER RESEARCH, 2018, 78 (04)
  • [26] MRI radiomics predicts progression-free survival in prostate cancer (vol 12, 974257, 2023)
    Jia, Yushan
    Quan, Shuai
    Ren, Jialiang
    Wu, Hui
    Liu, Aishi
    Gao, Yang
    Hao, Fene
    Yang, Zhenxing
    Zhang, Tong
    Hu, He
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [27] Progesteron receptor status as a predictor of progression-free survival and overall survival in patients with early breast cancer.
    Latiano, T.
    D'Addetta, C.
    Murgo, R.
    Piano, A.
    Morritti, M.
    Valori, V.
    Lombardi, L.
    Parrella, P.
    Copetti, M.
    Maiello, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Progression-free survival with regorafenib in gastric cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (08): : E323 - E323
  • [29] 18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
    Xu, Xiaojun
    Sun, Xun
    Ma, Ling
    Zhang, Huangqi
    Ji, Wenbin
    Xia, Xiaotian
    Lan, Xiaoli
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
    Mertz, Shirley
    Benjamin, Christine
    Girvalaki, Charis
    Cardone, Antonella
    Gono, Paulina
    May, Suepattra G.
    Comerford, Erin
    Than, Kyi-Sin
    Birch, Kelly
    Roach, Meaghan
    Myers, Sky
    Sasane, Medha
    Lavi, Liat
    Cameron, Anna
    Cardoso, Fatima
    BREAST, 2022, 65 : 84 - 90
12345